May 21, 2018

INTERVIEW: Norman Broadbent Plc 40 Years of success

Norman Broadbent Plc (LON:NBB) Michael Brennan Group CEO and Will Gerrand CFO talk to DirectorsTalk about what has been achieved since Michael joined 2 years ago, who the major shareholders..

INTERVIEW: SigmaRoc plc Results exceed expectations

SigmaRoc plc (LON:SRC) CEO Max Vermorken talks to DirectorsTalk about a great set of results published today. Max talks us through the highlights, explains the strategy of operating local businesses..

INTERVIEW: Live Company Group New Buenos Aires show sells out

Live Company Group Plc (LON:LVCG) Executive Chairman David Ciclitira talks to DirectorsTalk about its BRICKLIVE show arriving in Buenos Aires. David talks about the show, its partners, explains what is..

Allergy Therapeutics plc positive top-line results from its Grass MATA MPL Phase II dose ranging study

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announced highly positive top-line results from its Grass Modified Allergen Tyrosine Absorbed (MATA) MPL Phase..

4D pharma plc Monotherapy trial approved; the first live biotherapeutic trial in cancer

4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company has submitted, and the Medicines and Healthcare products Regulatory Agency (MHRA) has..

Gateley (Holdings) Plc To acquire GCL Solicitors LLP for £4.15 million

Gateley (Holdings) Plc (LON:GTLY), the national commercial law and complementary professional services group, has today announced it has entered into an agreement to acquire the business and assets of GCL..

SigmaRoc plc Exceed expectations in full year results

SigmaRoc plc (LON:SRC), the AIM listed buy-and-build construction materials group, has today announced its audited results for the year ended 31 December 2017. Financial highlights1 31 December 2017 31 December..

Search

Funds

May 21, 2018

Search

Funds

May 21, 2018

FTSE 100

Funds